Pharmaco - Press Releases

Date	Title	Company
24-Jan-2022	MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report	MorphoSys AG
24-Jan-2022	Original-Research: Defence Therapeutics Inc. (von GBC AG)	Defence Therapeutics Inc.
24-Jan-2022	Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022	aap Implantate AG
24-Jan-2022	Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs	RELIEF THERAPEUTICS Holding AG
24-Jan-2022	Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon 'Next-Gen' Colorectal Cancer Screening Test	Epigenomics AG
20-Jan-2022	VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
20-Jan-2022	Optimer® diagnostic reagent detects omicron variant	Aptamer Group
20-Jan-2022	Parse Biosciences Announces Partnership With Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region	Parse Biosciences
20-Jan-2022	Refeyn’s new SamuxMP mass photometer promises to significantly improve AAV workflows	Refeyn
20-Jan-2022	Vetter’s New Clinical Manufacturing Site Now Officially Authorized	Vetter
20-Jan-2022	The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia	Idorsia Ltd
20-Jan-2022	Transgene and BioInvent Joint JITC Publication Demonstrates the Potential of BT-001 Oncolytic Virus to provide therapeutic benefit beyond current anti-PD1/ anti-CTLA-4 immune checkpoint blockade	Transgene
20-Jan-2022	UAB announces first clinical-grade transplant of gene-edited pig kidneys into brain-dead human	UAB
20-Jan-2022	F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3	F-star Therapeutics, Inc.
20-Jan-2022	Takeda Named Global Top Employer for Fifth Consecutive Year	Takeda
20-Jan-2022	Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange	Cassiopea S.p.A.
20-Jan-2022	Kuros Biosciences publishes first-in-human clinical data for Fibrin-PTH (KUR-113) in treatment of open tibial shaft fractures	Kuros Biosciences AG
20-Jan-2022	Medacta Group SA reports strong revenue growth of 21.4% in 2021	Medacta Group SA
20-Jan-2022	Zur Rose Group: steady growth in a volatile market environment	Zur Rose Group AG
19-Jan-2022	Vetter’s New Clinical Manufacturing Site Now Officially Authorized	B3C newswire